- ►cardiobarbanza.com [PDF] DM Nathan, JB Buse, MB Davidson, E … - Diabetologia, 2009 - Springer Page 1. CONSENSUS STATEMENT UPDATE Medical management of hyperglycaemia in type
2 diabetes mellitus: a consensus algorithm for the initiation ... Cited by 1042 - Related articles - BL Direct - All 92 versions
- ►annals.org [PDF] J Rosenstock, B Zinman, LJ Murphy, SC … - Annals of internal medicine, 2005 - Am Coll Physicians Inhaled Insulin Improves Glycemic Control When Substituted for or ... Added to
Oral Combination Therapy in Type 2 Diabetes ... Julio Rosenstock, MD; Bernard
Zinman, MD; Liam J. Murphy, MD; Stephen C. Clement, MD; Paul Moore, MD; C. ... Cited by 163 - Related articles - BL Direct - All 8 versions
M Bayes, X Rabasseda, JR Prous - Methods and findings in experimental and clinical …, 2006 - journals.prous.com Contributing Editors: P. Cole, C. Orellana, JA Vallès, RM a . Antonijoan, KP
Mohana Priya, M. Priya, V. Renuga, R. Sree Lekha, B. Priya, A. Tomillero, G.
Krithiga and E. Banu Rekha. Cited by 148 - Related articles - All 9 versions
- ►endojournals.org SE Fineberg, T Kawabata, D Finco-Kent, C Liu … - Journal of Clinical Endocrinology & Metabolism, 2005 - Endocrine Soc Research Design and Methods: Insulin antibody data from initial phase II/III
trials were analyzed comparing the efficacy and safety of inhaled insulin with
various agents, including sc insulin. Additionally, data from a 24-month ... Cited by 119 - Related articles - All 6 versions
- ►diabetesjournals.org K Rave, S Bott, L Heinemann, S Sha, RHA … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—INH had a faster onset of action than both RHI and ILP, as indicated
by shorter time to early half-maximal effect (32 vs. 48 and 41 min,
respectively; P < 0.001 for IHN vs. RHI and P < 0.05 for IHN vs. ILP). Time ... Cited by 112 - Related articles - All 7 versions
- ►ucalgary.ca [PDF] - Free from Publisher JS Skyler, RS Weinstock, P Raskin, JF Yale, E … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Mean glycosylated hemoglobin (A1C) decreased comparably from baseline
in the inhaled and subcutaneous insulin groups (−0.3 and −0.1%,
respectively; adjusted difference −0.16% [CI −0.34 to 0.01]), with a ... Cited by 104 - Related articles - BL Direct - All 10 versions
- Free from Publisher T Heise, S Bott, C Tusek, JA Stephan, T … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—For the INH and SC groups, mean (±SD) IAB levels were 3.5 ± 3.9 and
2.6 ± 4.1 μU/ml at baseline, respectively, compared with 101.4 ± 140.4 and
4.3 ± 9.4 μU/ml at week 24. At week 24, the changes from baseline were ... Cited by 80 - Related articles - BL Direct - All 6 versions
- ►annals.org [PDF] L Ceglia, J Lau, AG Pittas - Annals of internal medicine, 2006 - Am Coll Physicians Page 1. Meta-Analysis: Efficacy and Safety of Inhaled Insulin Therapy in
Adults with Diabetes Mellitus Lisa Ceglia, MD; Joseph Lau ... Cited by 63 - Related articles - BL Direct - All 7 versions
- ►adisonline.com [PDF] R Oiknine, M Bernbaum, AD Mooradian - Drugs, 2005 - pt.wkhealth.com Insulin is one of the oldest and best studied treatments for diabetes mellitus.
Despite many improvements in the management of diabetes, the nonphysiological
time-action profiles of conventional insulins remain a significant ... Cited by 59 - Related articles - All 5 versions
- ►diabetesjournals.org RHA Becker, S Sha, AD Frick, RJ Fountaine - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—Before smoking cessation, maximum insulin concentration (C max ) and
area under the curve (AUC) for insulin concentration time (AUC-Insulin 0–360 )
with inhaled insulin were higher, and time to C max (t max ) shorter, in ... Cited by 59 - Related articles - BL Direct - All 6 versions
